Navigation Links
Convertible in Medical News

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

ANNAPOLIS, Md., July 27 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has signed definitive agreements for the issuance of 2-year, 10% unsecured sen...

Wyeth Announces Results of the Company's Offer Relating to Holder Right to Surrender Convertible Debentures

MADISON, N.J., July 15 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) (the "Company") announced today that the Company's offer to purchase Wyeth Floating Rate Convertible Senior Debentures due 2024 (the "Convertible Debentures") pursuant to the right of holders to surrender their Conve...

LodgeNet Interactive Announces Completion of Offering of $57.5 Million of Convertible Preferred Stock

SIOUX FALLS, S.D., June 29 /PRNewswire-FirstCall/ -- LodgeNet Interactive Corporation (Nasdaq: LNET ) today announced that it has successfully completed its offering of 50,000 shares of 10% Series B Cumulative Perpetual Convertible Preferred Stock, $0.01 par value, with a liquidation preference ...

Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding

SEATTLE, June 19 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced the final results of its separate concurrent fixed price exchange offers (each, an "Exchange Offer" and together, the "Exchange Offers") for any and all of the app...

Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding

SEATTLE, June 17 /PRNewswire-FirstCall/ -- Holders of Approximately 46.1% of Outstanding Notes Tendered in the Exchange Offers Outstanding Debt to be Reduced by Approximately $54.8 Million Future Annual Interest Expense Reduced by Approximately $3.4 Million...

HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock

BIRMINGHAM, Ala., June 12 /PRNewswire-FirstCall/ -- HealthSouth Corporation (NYSE: HLS ) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on July 15, 2009, to holders of r...

Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock

WALTHAM, Mass., May 22 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, has declared a dividend of $3.00 per share on its Serie...

Cephalon Announces Exercise of $65 Million Over-allotment Option on 2.50% Convertible Senior Subordinated Notes

FRAZER, Pa., May 22 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that the underwriters of its previously announced offering of $435 million in aggregate principal amount of 2.50% convertible senior subordinated notes due 2014 have exercised in full their over-allotmen...

Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line

Counter top converts to under counter system. Under counter ionizer converts to counter top for travel use. Carlsbad, CA (PRWEB) May 20, 2009 -- Getting the health benefits of ionized and alkaline mineral water at home or in the office has become a lot easier thanks t...

Cell Therapeutics, Inc. Intends to Offer to Exchange up to $89.2 Million of its Outstanding Convertible Notes in a 'Modified Dutch Auction' Tender Offer

SEATTLE, May 11 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI" or the "Company") (Nasdaq and MTA: CTIC) today announced that that its Board of Directors has authorized a "Modified Dutch Auction" tender offer (the "Exchange Offer") and that it intends to exchange shares of its common stoc...
Convertible in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...ff Position No. APB 14-1 (FSP 14-1) for its 2 5/8% convertible notes, which required Isis to assign a value to its convertible debt without considering the conversion feature. As a result, Isis is recording its convertible debt at a discount, which Isis is amortizing over ...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

... 5,417 ----- ----- Total current liabilities $45,316 $68,374 convertible subordinated notes 214,955 214,955 Capital lease obligations 19,616 20,347 ...

Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease

...es Greenhouse, Innovation Works (Pittsburgh), and several individual investors. The round included both new investments and the conversion of existing convertible notes. "This investment facilitates the advancement of our existing lead molecules towards a major milestone," said Cognition Therapeutics P...

Cardiogenesis Announces Presentation of its PHOENIX(R) Combination TMR Plus Stem Cell Delivery System at the International Society of Minimally Invasive Cardiothoracic Surgeons (ISMICS) Annual Meeting

...could adversely affect the market for our products or our ability to raise needed financing; actions by our competitors; restrictions contained in our convertible debt obligations requiring the issuance of shares rather than repayment in cash; and the company's ability to protect its intellectual property. Other...

Gen-Probe and DiagnoCure Amend Collaboration Agreement Surrounding PCA3-Based Prostate Cancer Tests

...dment, Gen-Probe will acquire 4.9 million shares of newly issued DiagnoCure convertible preferred stock for US$5.0 million (C$6.1 million), representing a premium ...ng the required regulatory approvals from the Toronto Stock Exchange. These convertible preferred shares are non-voting, and may be exchanged for common shares on ...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...GlaxoSmithKline (GSK) - - $106 million of convertible debt repurchased for $50 million in cash - ...$106.2 million principal amount of its outstanding convertible debt at a cost of $50.0 million in cash. The repu...9 million principal amount of the Company's 2 1/4% convertible Subordinated Notes Due October 2011, and $23.3 mil...

American Dairy Provides Business Update

...nnounces Repurchase of Additional $3.77 Million of convertible Notes - BEIJING, Jan. 20 /PRNewswire-FirstCal... Repurchase of an Additional $3.77 Million of convertible Notes The Company also announced that, as part ...Company's outstanding 1% Guaranteed Senior Secured convertible Notes due 2012 (the "2012 Notes"), the Company com...

Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay

...e with Nasdaq listing requirements, the impact of a possible reverse split of the shares of our common stock, the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to raise sufficient capital in the future, if required. For a discussion of other factors tha...

SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases

...dvancement of this novel compound." As part of the license agreement, Sunesis has earned a milestone payment from SARcode of $500,000 and a $375,000 convertible note. The next payable milestone, if earned, will be for initiation of the Phase 2 clinical program. About SARcode SARcode is a privately-held bio...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...ing capital $90,722 $107,844 Total assets $96,444 $119,282 4% convertible subordinated notes due 2011 $18,967 $69,890 Total long-term liabilities ...
Convertible in Medical Products

3.5v Streak Retinoscope Set with Convertible Handle and Soft Case

Description: Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Company:Welch Allyn Medical Products

3.5v Streak Retinoscope Set with Convertible Handle and Hard Case

Description: Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Company:Welch Allyn Medical Products

High Lite Convertible

Description: The Convertible lets you attach the High Lite optic directly to your loupes....
Company:BFW, Inc.

z.one Ultrasound Platform

Description:... images, Zone Sonography technology is more than just a revolutionary advancement. The z.one platform, powered by Zone Sonography, is the worlds first convertible Ultrasound system, instantly converting from a full-featured cart-based system into a premium compact, ultrasound system with all the performance of s...
Company:ZONARE Medical Systems

3.5v Standard Ophthalmoscope Set

Description:... 3.5v Standard Ophthalmoscope Set with convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Company:Welch Allyn Medical Products

3.5v Coaxial Ophthalmoscope Set

Description:... 3.5v Coaxial Ophthalmoscope Set with convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Company:Welch Allyn Medical Products

Ophthalmic Diagnostic Set

Features:...desk charger unit, two Lithium-Ion well charging handles delivering twice the on-time at half the weight of conventional NiCad power handles, plus the convertible handle (runs off NiCad rechargeable or C-cell batteries). ...
Company:Welch Allyn Medical Products

3.5v Ophthalmic Diagnostic Set with AutoStep

Features:...l optical system provides a shadow-free spot and easier entry into undilated pupils. Its illuminated lens dial clearly identifies settings. The convertible handle's smooth, non-abrasive knurled finish ensures a no-slip grip. The chrome-plated brass handle provides durable, long-life construction. ...
Company:Welch Allyn Medical Products

3.5v Ophthalmic Diagnostic Set

Features:...l optical system provides a shadow-free spot and easier entry into undilated pupils. Its illuminated lens dial clearly identifies settings. The convertible handle's smooth, non-abrasive knurled finish ensures a no-slip grip. The chrome-plated brass handle provides durable, long-life construction. ...
Company:Welch Allyn Medical Products
Convertible in Biological News

BIO-key to Respond in Court to a Lawsuit Filed by Two Investors

...ny improperly failed to redeem outstanding shares of the Company's Series B convertible Preferred Stock and Series C convertible Preferred Stock currently held by the investors in accordance with the term...

Explorations Group Acquires Hawk Biometric Technologies, Inc.

...older value." Shareholders of Hawk Biometric received a total of 600,000 shares of Explorations' Series B preferred stock, each share of which is convertible into 100 shares of Explorations' common stock. Explorations is planning a 1-for-6 reverse split of its common stock. The Series B preferred shares wi...

CACI Awarded a Prime Position on $500 Million, Multiple-Award Program with Biometrics Operations and Support Services

...ders under Government Wide Acquisition Contracts ("GWACs") and/or schedule contracts with the General Services Administration; and (iv) accounting for convertible debt instruments; our own ability to achieve the objectives of near term or long range business plans; and other risks described in the company's Secu...

Communication Intelligence Corporation Reports Third Quarter 2008 Financial Results

...ly. The increase in the net loss applicable to common stockholders is due primarily to a non-cash expense for the beneficial conversion feature of the convertible preferred shares issued in June 2008 of $371,000. There was no such charge in the comparable period of the prior year. The basic and diluted loss per ...

Synaptics Reports Record Results for First Quarter of Fiscal 2009

... 7,095 Other accrued liabilities 8,502 9,120 Total current liabilities 53,180 50,509 convertible senior subordinated notes 125,000 125,000 Other liabilities 18,200 17,075 Commitments and conti...

Communication Intelligence Corporation Reports Second Quarter 2008 Financial Results

...nded June 30, 2008, compared to $215,000 in the corresponding prior year period and to a non-cash expense for the beneficial conversion feature of the convertible preferred shares issued in June 2008 of $371,000. There was no such charge in the prior year comparable period. The basic and diluted loss per share w...

bioMETRX, Inc. Completes Sequiam Asset Purchase

...e issued. The shares issued are restricted securities that are subject to additional leak-out provisions after the holding period expires. There is no convertible debt tied to this transaction. As part of this transaction, BIL will convert $250,000 of debt into the company's common stock. "We are excited to ac...

Communication Intelligence Corporation Closes $3.6 Million Financing

...y with the closing of the Loan, the Company also issued 1,040,000 shares of convertible Preferred Stock (the "Preferred Shares") in exchange for the cancellation o...n preference of $1.00 per share over common stock. The Preferred Shares are convertible into common stock at the conversion price of $0.14 per share any time after...

Court Approves Scheme of Arrangement

...he scheme becoming effective, Shire Limited will be substituted in place of Shire plc as principal obligor under the U.S.$1,100,000,000 2.75 per cent. convertible Bonds due 2014 originally issued by Shire plc (and the terms and conditions of such bonds will be amended). Notes to Editors SHIRE PLC Shire's s...

BIO-key Reports Third Quarter 2007 Results

... amount in the 2006 period included $5.5 million from the extinguishment of convertible debt. The third quarter 2007 net loss per share was ($0.03) compared to a n... amount in the 2006 period included $7.8 million from the extinguishment of convertible debt compared to a similar item of $0.4 million for the nine months ended S...
Convertible in Biological Technology

Onyx Pharmaceuticals Announces Pricing of Concurrent Offerings of Four Million Shares of Common Stock and $200 Million Principal Amount of Convertible Senior Notes

EMERYVILLE, Calif., Aug. 6 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it has agreed to sell an aggregate of four million shares of its common stock at a price to the public of $30.50 per share and $200 million aggregate principal amou...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it has closed on the issuance of 2-year, 10% unsecured ...

Novavax Announces Repayment of $5 Million of Convertible Debt

ROCKVILLE, Md., July 15 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) today announced that it has repaid the remaining $5.0 million balance of its convertible notes. These convertible notes carried a coupon rate of 4.75% payable semi-annually and had a maturity date of July ...

Viral Genetics Retires Nearly $3.5 Million Convertible Debt and Provides Updates on Capital Structure and Stock Issuances

SAN MARINO, Calif., July 13 /PRNewswire-FirstCall/ -- Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, has retired the majority of its $3.5 million of convertible debt. The company also retired other ...

Verenium Completes Amendment to 8% Senior Convertible Notes

CAMBRIDGE, Mass., July 6 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM ) announced today that the agreement to amend the $29.5 million of outstanding 8% Senior Convertible Notes due April 1, 2012 (the "Notes") entered into and announced on July 1, 2009 is effective as of 8:00 a....

Schering-Plough Declares Quarterly Dividends on Common Shares and Mandatory Convertible Preferred Stock

KENILWORTH, N.J., June 23 /PRNewswire-FirstCall/ -- The Board of Directors of Schering-Plough Corporation (NYSE: SGP ) today declared a quarterly dividend of 6.5 cents per common share. Payment will be made on Aug. 31, 2009, to shareholders of record at the close of business on August 7, 2009. ...

Wyeth Announces Holder Right to Surrender Convertible Debentures

MADISON, N.J., June 16 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) (the "Company") announced today that holders of Wyeth Floating Rate Convertible Senior Debentures due 2024 (the "Convertible Debentures") have the right to surrender their Convertible Debentures for purchase by Wyeth pursuant to...

Cell Therapeutics Amends and Restates Its 'Modified Dutch Auction' Tender Offer to a Fixed Price Tender Offer for Any and All of Its $118.9 Million Outstanding Convertible Notes

SEATTLE, June 2 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (the "Company" or "CTI") (Nasdaq and MTA: CTIC) today announced that it has amended and restated its "Modified Dutch Auction" tender offer to a fixed price tender offer for any and all of the approximately $118.9 million outstanding...

Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings

FRAZER, Pa., May 21 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today the pricing of its concurrent public offerings of 5 million shares of common stock, at a price of $60 per share, and $435 million in aggregate principal amount of 2.50% convertible senior subordinated no...

Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes

FRAZER, Pa., May 20 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH ) announced today that it intends to offer, subject to market and other conditions, $300 million of common stock and $350 million in aggregate principal amount of convertible senior subordinated notes due 2014 through t...
Other Tags
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Mike Billings , PT, MS, CEEAA, President ... PT, MBA, GCS, Director of Professional Development to discuss ... of the Improving Medicare Post-Acute Care Transformation Act ... the Infinicast, the two leaders discuss how the IMPACT ... to standardize post-acute assessment data for quality, payment, and ...
(Date:12/24/2014)... (HealthDay News) -- A new, injectable weight-loss drug has ... The agency on Tuesday approved Saxenda (liraglutide) for ... overweight and have at least one weight-related health condition, ... high cholesterol. Patients taking the drug, made by ... exercise regularly, the FDA noted. "Obesity is a ...
(Date:12/24/2014)... Steven Reinberg HealthDay ... New guidelines from the American Diabetes Association (ADA) call for ... with diabetes to help prevent heart disease. These new ... of Cardiology and American Heart Association, which also recommend giving ... heart disease, including people with diabetes. "We agree that ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 24, 2014 ... COC Industry is a professional and in-depth research ... the report introduces COC basic information, including its ... policy analysis, news analysis, etc. This report also ... structure etc. Production is separated by regions, technology ...
Breaking Medicine News(10 mins):Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 2Health News:COC/ Cyclic Olefin Copolymer Market: Global 2015-2020 Forecasts & Research Report Now at DeepResearchReports.com 3
(Date:12/22/2014)... , Dec. 22, 2014 Research ... has announced the addition of the ... report to their offering. ... insight provides an overview of the global ... aims to control and monitor piracy by ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ... funding to expand its team and bring LaunchKey to ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ... "Global Chemical Sensor Market 2015-2019" report to ... One major trend upcoming in ... sensors in biomedical applications. Chemical sensors help in ... diagnosis during surgical procedures. The Global Chemical Sensor ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
Other Contents